Research And Development
Health
Manufacturing

ACADIA Pharmaceuticals

1,775

$41.79
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (+0.18%) As of 12:16 PM EDT today
+$0.07 (+0.18%) Today

Why Robinhood?

You can buy or sell ACAD and other stocks, options, ETFs, and crypto commission-free!

About ACAD

ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. The firms product include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. Read More The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

CEO
Stephen R. Davis
Employees
503
Headquarters
San Diego, California
Founded
1993
Market Cap
6.52B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.43M
High Today
$42.30
Low Today
$40.90
Open Price
$42.24
Volume
324.76K
52 Week High
$53.70
52 Week Low
$21.56

Collections

Research And Development
Health
Manufacturing
Pharmaceutical
Technology
Medical
Biotechnology

ACAD Earnings

-$0.59
-$0.39
-$0.20
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected Apr 29, After Hours

People Also Bought

Bristol-Myers Squibb

10,390

$57.53

+1.11%

Bristol-Myers Squibb

10,390

$57.53

+1.11%

Amarin

34,020

$5.70

+13.05%

Micron Technology

47,682

$48.28

+3.74%

AbbVie

32,137

$76.84

+1.92%

You May Also Like

VERB
LPTX
FTGC
GLV
GEL
ZDGE
KSA
DHS
AIRTW
CLR
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy ACAD

Market Price$41.79
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell ACAD stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up